Company: SONM
Filing Date: 2025-09-29
Form Type: S-1
Source: 0001493152-25-016055
Chunk: 27

Company: SONIM TECHNOLOGIES INC
Filing Date: 2025-09-29
Form: S-1
Chunk 27
---
 the shares of Common Stock issued        
 and sold to Chardan under the Facility, multiplied by the VWAP Purchase Price (or Intraday VWAP Purchase Price), assuming for illustrative 
 purposes that the VWAP Purchase Price (or Intraday VWAP Purchase Price) is equal to 96.5% of the assumed trading price of                  
 Common Stock listed in the first column.                                                                                                   |
| (2) | Represents                                                                                                                                 
 the closing price of our Common Stock on Nasdaq on September 26, 2025.                                                                     |
| (3) | The                                                                                                                                        
 number of shares of our Common Stock offered by this prospectus may not cover all the shares of our Common Stock we ultimately may         
 sell to Chardan under the Purchase Agreement. We have included in this column only those shares of our Common Stock being offered          
 for resale by Chardan under this prospectus, (i) giving effect to the Exchange Cap (as applicable) and (ii) without regard                 
 to the Beneficial Ownership Limitation.                                                                                                    |

| 14 |

<div align='center'>Use of Proceeds</div>

All of the shares of our Common Stock offered by Chardan will be solely for Chardan’s account. We will not receive any of the proceeds from these sales. We may receive up to $500.0 million in aggregate gross proceeds from Chardan under the Purchase Agreement in connection with sales of our shares of our Common Stock to Chardan pursuant to the Purchase Agreement from time to time after the date of this prospectus. However, the actual proceeds we receive may be less than this amount (before being reduced for the discount to Chardan) depending on the number of share of our shares of our Common Stock sold and the price at which the shares of our Common Stock are sold.

A minimum of thirty-three percent (33%) of such proceeds will be applied to the pre-payment of the July Note, pursuant to the terms of the July Note. The Company intends to use any remaining proceeds for our operations, to support our overall business strategy, for working capital purposes, and for general corporate purposes, which may include repayment and refinancing of our indebtedness. Pending other uses, we intend to invest the net proceeds to us in investment-grade, interest-bearing securities such as money market funds, certificates of deposit, or direct or guaranteed obligations of the U.S. government, or hold as cash. We cannot predict whether the net proceeds invested will yield a favorable return. We will have broad discretion